2020 American Transplant Congress » Poster Session B: Kidney Immunosuppression: Novel Regimens and Drug Minimization
Date: Saturday, May 30, 2020
Time: 3:15pm-4:00pm
Location: Virtual
Session Type: Poster Session
Meeting: 2020 American Transplant Congress
- 3:30pm-4:00pm
11 Years Experience of Early Steroid Withdrawal Immunosupression Protocol in Kidney Allograft Recipient
O. Adebiyi, A. Sharfuddin, M. Yaqub, D. Mishler, T. Taber, W. Goggins
- 3:30pm-4:00pm
A Single Centre Experience of Conversion from Immediate Release Tacrolimus (IR-tac) to Extended Release Envarsus
S. Chong1, E. Kent2, C. Beligaswatta2, P. Gudka2, C. Magee2, M. Harber2, R. Motallebzadeh1, G. Jones2
- 3:30pm-4:00pm
Clinical Implications of Tacrolimus Time in Therapeutic Range in Urban Renal Transplant Recipients Under an Early Corticosteroid Withdrawal Protocol
D. Pierce, P. West-Thielke, Z. Hajjiri, S. Gaitonde, I. Tzvetanov, E. Benedetti, A. Lichvar
- 3:30pm-4:00pm
Discontinuation Rates in Multicenter Trials – Are They Driven by Attitudes or Facts?
B. Nashan1, F. Braun2, D. Dragun3, I. A. Hauser3, P. Schemmer2, H. J. Schlitt2, C. Sommerer3, B. Suwelack3, C. Schiedel4, I. Kroeger4, F. Thaiss3
- 3:30pm-4:00pm
Late Conversion from Calcineurin Inhibitors to Belatacept in Kidney-Transplant Recipients Has a Significant Beneficial Impact on Glycemic Parameters
J. Noble, F. Terrec, T. Jouve, H. Neciri Bennani, P. Benhamou, P. Malvezzi, B. Janbon, D. Giovannini, L. Rostaing
- 3:30pm-4:00pm
Late De Novo Donor Specific Antibodies in Steroid Free Immunosuppression and Delayed Graft Function
S. Karhadkar, M. Falz, A. Diamond, A. Di Carlo, O. Timofeeva
- 3:30pm-4:00pm
New Everolimus Administration Targeting the Prevention of the Development of Antibody-Mediated Rejection Considering the Comparison of Growth and Survival in IgG and IgM Memory B Cells
Y. Matsuda1, R. Imamura1, H. Tezuka2, S. Takahara1
- 3:30pm-4:00pm
Outcomes of De Novo Belatacept-Based Immunosuppression in Recipients of Kidneys at High Risk for Delayed Graft Function in the Setting of Lymphocyte Depleting Immune Modulation
T. L. Shertel1, M. A. Wynd1, M. A. Pereiras1, J. T. McKeen1, Y. Y. Yushkov2, B. R. Schleich3, S. E. Geatrakas2, A. Patel2, M. J. Goldstein2
- 3:30pm-4:00pm
Steroid Dependence at 1 Yr in Kidney Transplant Recipients Initiated on Early Steroid Withdrawal Protocol: Associated Risk Factors and Prognosis
M. Yaqub, D. Mishler, T. Taber, A. Sharfuddin, W. Goggins, O. Adebiyi
- 3:30pm-4:00pm
Treatment of De Novo Renal Transplant Recipients with Calcineurin Inhibitor (CNI)-Free, Belatacept+Everolimus-Based Immunosuppression
V. R. Peddi1, B. Marder2, L. Gaite3, J. Oberholzer4, R. Goldberg5, T. Pearson6, H. Yang7, L. Allamassey8, S. Gao8, M. Polinsky8, R. N. Formica9
- 3:30pm-4:00pm
Use of Tacrolimus Extended-Release in Elderly Kidney Transplant Recipients
S. January1, J. Hagopian1, N. Nesselhauf1, K. Progar1, R. Delos Santos2
« View all sessions from the 2020 American Transplant Congress